Vir Biotechnology, Inc.
VIR · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $3 | $5 |
| - Cash | $0 | $0 | $1 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $3 | $5 |
| Revenue | $0 | $0 | $2 | $1 |
| % Growth | -13.9% | -94.7% | 47.5% | – |
| Gross Profit | -$0 | -$0 | $1 | $1 |
| % Margin | -545% | -564.7% | 61.6% | 53.1% |
| EBITDA | -$1 | -$1 | $1 | $0 |
| % Margin | -685.8% | -744.5% | 52% | 38.9% |
| Net Income | -$1 | -$1 | $1 | $1 |
| % Margin | -703.4% | -713.7% | 31.9% | 48.3% |
| EPS Diluted | -3.83 | -4.59 | 3.83 | 3.96 |
| % Growth | 16.6% | -219.8% | -3.3% | – |
| Operating Cash Flow | -$0 | -$1 | $2 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$1 | $2 | -$0 |